申请人:Hoechst-Roussel Pharmaceuticals Inc.
公开号:US05356910A1
公开(公告)日:1994-10-18
There is disclosed a method of alleviating obsessive compulsive disorders which comprises administration of an effective amount of a compound of the formula. ##STR1## where m is 1 or 2; R is H, halogen, loweralkyl, loweralkoxy, arylloweralkoxy, hydroxy, nitro, amino, loweralkylamino or diloweralkylamino; R.sub.1 is H or loweralkyl; R.sub.2 is H or loweralkyl; and R.sub.3 is H, halogen or loweralkyl.
揭示了一种缓解强迫症障碍的方法,其中包括给予公式化合物的有效量。##STR1## 其中m为1或2;R为H、卤素、较低烷基、较低烷氧基、芳基较低烷氧基、羟基、硝基、氨基、较低烷基氨基或二较低烷基氨基;R.sub.1为H或较低烷基;R.sub.2为H或较低烷基;R.sub.3为H、卤素或较低烷基。